About Arthritis Research & Therapy
This page includes information about the aims and scope of Arthritis Research & Therapy, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Arthritis Research & Therapy is an international, peer-reviewed online journal, publishing original research, reviews, commentaries and reports. The major focus of the journal is on cellular and molecular mechanisms of arthritis, musculoskeletal conditions and systemic autoimmune rheumatic diseases and translation of this knowledge into advances in clinical care. Original basic, translational laboratory and clinical research is considered for publication along with results of therapeutic trials.
All Research articles, Commentaries, Editorials, Letters, Meeting reports and Reviews articles published by Arthritis Research & Therapy are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. In addition, the journal also publishes reviews and other article types that are only available by subscription.
Authors of Research articles, Commentaries, Editorials, Letters, Meeting reports and Reviews articles published in Arthritis Research & Therapy are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
In addition to research articles Arthritis Research & Therapy also publishes all of which are only available by subscription. BioMed Central holds the copyright to such subscription content according to the terms of BioMed Central's Copyright Licensing Agreement.
Open access publishing is not without costs. Arthritis Research & Therapy therefore levies an article-processing charge of £1325/$2255/€1675 for each Research articles, Commentaries, Editorials, Letters, Meeting reports and Reviews article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
All articles published in Arthritis Research & Therapy are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Arthritis Research & Therapy include:
- Current contents
- Global Health
- Google Scholar
- PubMed Central
- Science Citation Index
- Science Citation Index Expanded
The full text of all research articles published by BioMed Central is also available on SpringerLink.
Arthritis Research & Therapy is tracked by Thomson Reuters (ISI) and has an Impact Factor of 4.12.
Publication and peer review process
Criteria for publication
Research articles: reports of data from exceptional original research. These articles will form the major content of the journal.
Reviews: provide a full and factual account of recent developments within an area of research and are usually commissioned by the journal. In-depth reviews provide substantial coverage of a subject in a single longer article, and multi-author thematic series explore a subject in a series of concise, narrowly focused review articles coordinated by a leading authority in the field.
Commentaries: short, focused and opinionated articles of contemporary interest on any subject within the journal's scope. Most are commissioned, although unsolicited commentaries are welcome and are routinely peer reviewed.
Editorials: short articles focusing on interesting research articles recently published in Arthritis Research & Therapy, explaining the implications of the article and putting it in context. They are commissioned by the journal.
Letters: discuss material published in Arthritis Research & Therapy. Letters are not usually peer reviewed but on occasion we may invite replies for publication in the same issue.
Meeting reports: short descriptions of a conference that an author has attended, which should focus on the key developments presented and discussed at the meeting. Most reports are commissioned and most authors are practicing arthritis researchers or clinicians.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Arthritis Research & Therapy, a personalized section of the site.
Copyediting and proofs
All articles published in Arthritis Research & Therapy are copyedited before publication of the final version.
Research articles, Commentaries, Editorials, Letters, Meeting reports and Reviews articles published in Arthritis Research & Therapy are published immediately on acceptance in the form of a provisional PDF. Copyedited and fully formatted PDF and full-text (HTML) versions are made available shortly after that.
Edited versions will be sent by email and corrections should be returned within two working days. Please provide a typed list of corrections clearly indicating where the corrections should be made and please send this list by email.
The editing of Research articles, Commentaries, Editorials, Letters, Meeting reports and Reviews articles is designed only to correct such things as misused words, spelling errors, missing references or incomplete citation information.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Arthritis Research & Therapy will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to Arthritis Research & Therapy should adhere to BioMed Central's editorial policies.
Citing articles in Arthritis Research & Therapy
Articles in Arthritis Research & Therapy should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Arthritis Res Ther [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Arthritis Res Ther 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Arthritis Research & Therapy?
Arthritis Research & Therapy's open access policy allows maximum visibility of research articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Arthritis Research & Therapy offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Arthritis Research & Therapy, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in Arthritis Research & Therapy gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Arthritis Research & Therapy are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Arthritis Research & Therapy's pages and on the BioMed Central homepage.
In addition, articles published in Arthritis Research & Therapy may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Arthritis Research & Therapy. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of research articles published in Arthritis Research & Therapy retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.